West Oak Capital, LLC - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
West Oak Capital, LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$2,0000.0%1000.0%0.00%0.0%
Q3 2020$2,000
+100.0%
1000.0%0.00%0.0%
Q2 2020$1,000
-50.0%
1000.0%0.00%0.0%
Q1 2020$2,0000.0%1000.0%0.00%0.0%
Q4 2019$2,000
+100.0%
1000.0%0.00%0.0%
Q3 2019$1,000
-50.0%
1000.0%0.00%0.0%
Q2 2019$2,0000.0%1000.0%0.00%0.0%
Q1 2019$2,000
-99.9%
1000.0%0.00%0.0%
Q4 2018$1,766,000
-2.7%
1000.0%0.00%0.0%
Q3 2018$1,815,000
-7.2%
1000.0%0.00%0.0%
Q2 2018$1,955,000
+11.4%
1000.0%0.00%0.0%
Q1 2018$1,755,0001000.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q3 2023
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 715,351$11,617,0000.23%
ARK Investment Management 411,880$6,689,0000.17%
Nikko Asset Management Americas, Inc. 532,825$8,653,0000.14%
HHLR ADVISORS, LTD. 235,214$3,820,0000.05%
Vident Investment Advisory, LLC 17,479$284,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 532,825$8,653,0000.01%
MEEDER ASSET MANAGEMENT INC 3,195$52,0000.00%
Russell Investments Group, Ltd. 67,474$1,094,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 312,782$5,078,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$303,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders